5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with n-propionylprocainamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Book, M; Hahn, M; Luedi, MM; Rieder, HU; Stamer, UM; Stüber, F | 1 |
Chen, W; Fang, Y; Guo, N; Guo, Q; Lv, J; Wang, Z; Zeng, S; Zhao, Z | 1 |
2 other study(ies) available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and n-propionylprocainamide
Article | Year |
---|---|
ASA Status,
Topics: Atrial Natriuretic Factor; Coronary Artery Disease; Haplotypes; Humans; Natriuretic Peptide, Brain; Natriuretic Peptides; Nitrobenzoates; Peptide Fragments; Procainamide | 2022 |
Dose-dependent Effects of PRC2 and HDAC Inhibitors on Cardiomyocyte Hypertrophy Induced by Phenylephrine.
Topics: Animals; Cardiomegaly; Histone Deacetylase Inhibitors; Histones; Myocytes, Cardiac; Natriuretic Peptides; Phenylephrine; Rats | 2023 |